Brian E. Fisher

发表

Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response.

D. Levens, Eric Batchelor, Julia C. Liu, 2017, Molecular cell.

Acceleration of Hepatitis C Virus Envelope Evolution in Humans Is Consistent with Progressive Humoral Immune Selection during the Transition from Acute to Chronic Infection

Stuart C. Ray, S. Ray, Brian E. Fisher, 2010, Journal of Virology.

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.

S. Ray, Brian E. Fisher, David L. Thomas, 2010, Gastroenterology.

Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein

D. Ambrozak, B. Graham, R. Loomis, 2022, bioRxiv.

Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition.

J. Mascola, S. Pittaluga, M. Kanekiyo, 2022, Immunity.

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution

S. Ray, Brian E. Fisher, D. Thomas, 2012, Hepatology.

p53 Pulses Diversify Target Gene Expression Dynamics in an mRNA Half-Life-Dependent Manner and Delineate Co-regulated Target Gene Subnetworks.

Eric Batchelor, Joshua R. Porter, Brian E. Fisher, 2016, Cell systems.

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

U. Baxa, J. Mascola, R. Koup, 2018, Nature Immunology.

Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality

J. Mascola, A. Barrett, T. Pierson, 2020, Science Translational Medicine.

A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies

J. Mascola, M. Kanekiyo, B. Graham, 2020, Nature Communications.

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

U. Baxa, J. Mascola, R. Koup, 2018, Nature Immunology.

Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.

J. Mascola, Reda Rawi, T. Zhou, 2022, Immunity.

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

J. Mascola, M. Kanekiyo, B. Graham, 2020, Nature Communications.

Development of a potent Zika virus vaccine using self-amplifying messenger RNA

Jessica L. Cohen, J. Mascola, T. Pierson, 2020, Science Advances.

EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination

J. Mascola, M. Kanekiyo, B. Graham, 2023, Science advances.

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection

T. Pierson, C. Hsiao, B. Graham, 2022, bioRxiv.

Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses

J. Mascola, Reda Rawi, T. Zhou, 2022, bioRxiv.

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

J. Mascola, M. Kanekiyo, B. Graham, 2020, Nature Communications.

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution

S. Ray, Brian E. Fisher, D. Thomas, 2012, Hepatology.

Prefusion stabilization of the Hendra and Langya virus F proteins

D. Ambrozak, R. Loomis, Brian E. Fisher, 2024, Journal of virology.

Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase.

Reda Rawi, M. Kanekiyo, Rebecca A. Gillespie, 2024, Immunity.